ArticleMolecular medicine (Cambridge, Mass.)2025

ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

Mirian Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.